Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.

@article{Miceli2015IsavuconazoleAN,
  title={Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.},
  author={Marisa H Miceli and CarolA. Kauffman},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2015},
  volume={61 10},
  pages={
          1558-65
        }
}
Isavuconazole is a new extended-spectrum triazole with activity against yeasts, molds, and dimorphic fungi. It is approved for the treatment of invasive aspergillosis and mucormycosis. Advantages of this triazole include the availability of a water-soluble intravenous formulation, excellent bioavailability of the oral formulation, and predictable pharmacokinetics in adults. A randomized, double-blind comparison clinical trial for treatment of invasive aspergillosis found that the efficacy of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 43 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

and Drug Administration

  • US Foo
  • Isavuconazonium—invasive aspergillosis and…
  • 2015
Highly Influential
9 Excerpts

In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi

  • GM Gonzalez
  • Med Mycol
  • 2009
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…